# Double-Blind Treatment of Major Depressive Disorder With Vilazodone

> **NCT01742832** · PHASE2 · COMPLETED · sponsor: **University of Chicago** · enrollment: 79 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Vilazodone
- **DRUG:** Citalopram

## Key facts

- **NCT ID:** NCT01742832
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2023-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01742832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01742832, "Double-Blind Treatment of Major Depressive Disorder With Vilazodone". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01742832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*